tiprankstipranks
Trending News
More News >
Argent Biopharma (RGTLF)
OTHER OTC:RGTLF
US Market
Advertisement

Argent Biopharma (RGTLF) Technical Analysis

Compare
31 Followers

Technical Sentiment

Overall Consensus
Neutral
9Bullish
4Neutral
8Bearish
Technical Analysis Consensus
Sell
2Bullish
4Neutral
3Bearish
Moving Average Consensus
Buy
7Bullish
0Neutral
5Bearish
Argent Biopharma’s (RGTLF) Moving Averages Convergence Divergence (MACD) indicator is <0.01, suggesting Argent Biopharma is a Sell.
Argent Biopharma’s (RGTLF) 20-Day exponential moving average is 0.06, while Argent Biopharma’s (RGTLF) share price is <$0.1, making it a Buy.
Argent Biopharma’s (RGTLF) 50-Day exponential moving average is 0.06, while Argent Biopharma’s (RGTLF) share price is <$0.1, making it a Sell.

Argent Biopharma (RGTLF) Pivot Points

Aug 22, 2025, 03:09 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
0.01
0.03
0.05
0.07
0.08
0.11
0.12
Fibonacci
0.03
0.05
0.06
0.07
0.09
0.09
0.11
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Argent Biopharma (RGTLF) Moving Averages

Aug 22, 2025, 03:09 AM
Period
Simple
Exponential
MA5
0.06Buy
0.06Buy
MA10
0.06Buy
0.06Buy
MA20
0.06Buy
0.06Buy
MA50
0.05Buy
0.06Sell
MA100
0.07Sell
0.08Sell
MA200
0.13Sell
0.15Sell
Argent Biopharma’s (RGTLF) 10-Day exponential moving average is 0.06, while Argent Biopharma’s (RGTLF) share price is <$0.1, making it a Buy.
Argent Biopharma’s (RGTLF) 100-Day exponential moving average is 0.08, while Argent Biopharma’s (RGTLF) share price is <$0.1, making it a Sell.
Argent Biopharma’s (RGTLF) stock price is <$0.1 and Argent Biopharma’s (RGTLF) 50-day simple moving average is 0.05, creating a Buy signal.
Argent Biopharma’s (RGTLF) stock price is <$0.1 and Argent Biopharma’s (RGTLF) 100-day simple moving average is 0.07, creating a Sell signal.
Argent Biopharma’s (RGTLF) stock price is <$0.1 and Argent Biopharma’s (RGTLF) 200-day simple moving average is 0.13, creating a Sell signal.

Argent Biopharma (RGTLF) Technical Indicators

Aug 22, 2025, 03:09 AM
Name
Value
Implied Action
RSI (14)
56.49
Neutral
STOCH (9,6)
25.00
Neutral
STOCHRSI (14)
25.00
Neutral
MACD (12,26)
<0.01
Sell
ADX (14)
29.49
Neutral
Williams %R
-75.00
Buy
CCI (14)
202.51
Sell
ATR (14)
0.01
-
Ultimate Oscillator
18.70
Sell
ROC
0.00
Sell
Argent Biopharma’s (RGTLF) Relative Strength Index (RSI) is 56.49, creating a Neutral signal.
Argent Biopharma’s (RGTLF) Trend Strength Indicator (ADX) is 29.49, creating a Neutral signal.
Argent Biopharma’s (RGTLF) Commodity Channel Index (CCI) is 202.51, creating a Sell signal.

FAQ

Is RGTLF a Buy, Hold, or Sell?
Based on RGTLF’s technical indicators, RGTLF is a Hold.
    What is RGTLF’s RSI (14)?
    RGTLF’s RSI (14) is 56.49, which suggests RGTLF is a Neutral.
      What is RGTLF’s MACD?
      RGTLF’s MACD is <0.01, which suggests RGTLF is a Sell.
        What is RGTLF’s 5-day moving average?
        RGTLF’s 5-day moving average is 0.06, which suggests RGTLF is a Buy.
          What is RGTLF’s 20-day moving average?
          RGTLF 20-day moving average is 0.06, which suggests RGTLF is a Buy.
            What is RGTLF’s 50-day moving average?
            RGTLF’s 50-day moving average is 0.05, which suggests RGTLF is a Buy.
              What is RGTLF’s 200-day moving average?
              RGTLF’s 200-day moving average is 0.13, which suggests RGTLF is a Sell.
                What is RGTLF’s Williams % R (14)?
                RGTLF’s Williams % R (14) is -75.00, which suggests RGTLF is a Buy.
                  What is RGTLF’s CCI (14)?
                  RGTLF’s CCI (14) is 202.51, which suggests RGTLF is a Sell.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis